§ Federal grant opportunity · PAR-27-119
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
National Institutes of Health is accepting applications for Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed). The deadline is Rolling / not published and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- Rolling / not published
- Award range
- Award amount not published
- Eligibility
- nonprofits non higher education with 501c3, federally recognized native american tribal governments, public and indian housing authorities, nonprofits non higher education without 501c3, other native american tribal organizations, city or township governments, county governments, special district governments, other, small businesses, state governments, public and state institutions of higher education, independent school districts, private institutions of higher education, for profit organizations other than small businesses
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- PAR-27-119
Program overview
The Center for Inherited Disease Research (CIDR) carries out high-throughput genotyping and sequencing and supports statistical genetics services designed to 1) aid identification of genes or genetic modifications that contribute to human health and disease or 2) enhance the classification and characterization of well-phenotyped specimens by the addition of genotype or next-generation sequence data. The laboratory specializes in genomic services that cannot be efficiently carried out in individual investigator laboratories. CIDR provides the most up-to-date platforms, services, and statistical genetic support. This is an NIH-wide initiative that is administered by NHGRI. Information about current services offered can be accessed via: https://cidr.jhmi.edu .
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before Rolling / not published, allowing time for registration and validation.
Related grant opportunities
- Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)
- Indian Housing Block Grant Competitive Program (IHBG-COMP) for FY 2026
- Residential Treatment for Pregnant and Postpartum Women
- Assisted Outpatient Treatment
- Multilateral Partnerships Leveraging Excellence
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.